Enanta Pharmaceuticals, Inc. · NASDAQ:ENTA
Deep Track Capital, LP's stake in Enanta Pharmaceuticals, Inc. fell to 4.97% (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
Deep Track Capital, LP's stake in Enanta Pharmaceuticals, Inc. fell to 4.97%, 1,444,167 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 4.97%
- Shares
- 1,444,167
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Deep Track Capital, LP | 4.97% | 1,444,167 |
| Deep Track Biotechnology Master Fund, Ltd. | 4.97% | 1,444,167 |
| David Kroin | 4.97% | 1,444,167 |
Source
Related
- Enanta Pharmaceuticals, Inc.
- Deep Track Capital, LP
- Enanta Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · Deep Track Capital, LP · Feb 13, 2026
- Schedule 13G · Deep Track Capital, LP · Oct 9, 2025
- Schedule 13G/A · Farallon Capital Management, L.L.C. · Aug 14, 2026
- Form 4 · Rottinghaus Scott T. · Aug 10, 2026
- Schedule 13G/A · The Vanguard Group · Mar 26, 2026
- Schedule 13G/A · Dapice Joshua J. · Feb 5, 2026
- Schedule 13G/A · Millennium Management LLC · Jan 20, 2026